Search - tctmd.com

Displaying 1 - 17 of 17

Sort: Relevancy | Date

News Opinion Editor's Corner ACC 2025

What’s Going to Be Hot at ACC 2025?

Michael O'Riordan

March 26, 2025

News Daily News

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

Yael L. Maxwell

February 20, 2025

News Opinion Editor's Corner ACC 2023

What’s Going to Be Hot at ACC/WCC 2023?

Shelley Wood

February 27, 2023

News Daily News

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

Michael O'Riordan

February 23, 2023

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Conference News TCT 2022

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Michael O'Riordan

September 18, 2022

News Daily News

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

Michael O'Riordan

July 18, 2022

News Opinion Editor's Corner AHA 2021

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Shelley Wood

November 08, 2021

News Conference News EAS 2021

Lp(a) Not Associated With Ongoing Aortic Valve Calcification

Michael O'Riordan

June 04, 2021

News Daily News

Short-term Mortality Higher in Transfused TAVR Patients

Todd Neale

December 10, 2020

News Conference News AHA 2016

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Shelley Wood

November 09, 2016

News Daily News

Survival After Septal Ablation for HOCM Similar to General Population

L.A. McKeown

February 06, 2014

Presentation Cell Therapy 2013

Clinical Trials for Non-Ischemic Cardiomyopathy: Rationale and Study Design

Presenter: Leslie Miller

January 24, 2013

News Daily News

La Ablación Septal con Alcohol Rivaliza con la Miectomía en el Tratamiento de la Cardiomiopatía Hipertrófica Obstructiva

L.A. McKeown

October 23, 2012

News Daily News

Alcohol Septal Ablation Rivals Myectomy for Obstructive Hypertrophic Cardiomyopathy

L.A. McKeown

October 23, 2012

News Daily News

‘Valve-in-Valve’ Technique Effective in Treating CoreValve Leaks

Jason Kahn

March 06, 2011

Advertisement

What’s Going to Be Hot at ACC 2025?

Aortic Stenosis Slowed by SGLT2 Inhibitors in Observational Study

What’s Going to Be Hot at ACC/WCC 2023?

For TAVI Patients With CAD, Lifetime Management Is Key: EAPCI

December 2022 News Roundup

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Early Redo TAVI Outcomes Look Good, but ‘Far From Definitive’

AHA 2021 Tackles AF Triggers, Watchful Waiting in AS, Data Overload, and More

Lp(a) Not Associated With Ongoing Aortic Valve Calcification

Short-term Mortality Higher in Transfused TAVR Patients

AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR

Survival After Septal Ablation for HOCM Similar to General Population

Clinical Trials for Non-Ischemic Cardiomyopathy: Rationale and Study Design

La Ablación Septal con Alcohol Rivaliza con la Miectomía en el Tratamiento de la Cardiomiopatía Hipertrófica Obstructiva

Alcohol Septal Ablation Rivals Myectomy for Obstructive Hypertrophic Cardiomyopathy

‘Valve-in-Valve’ Technique Effective in Treating CoreValve Leaks

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content